• Benign Prostatic Hyperplasia
  • Hormone Therapy
  • Genomic Testing
  • Next-Generation Imaging
  • UTUC
  • OAB and Incontinence
  • Genitourinary Cancers
  • Kidney Cancer
  • Men's Health
  • Pediatrics
  • Female Urology
  • Sexual Dysfunction
  • Kidney Stones
  • Urologic Surgery
  • Bladder Cancer
  • Benign Conditions
  • Prostate Cancer

Lithotripter gains FDA approval; urease inhibitor now available in U.S.

Article

EDAP TMS SA has received FDA clearance to market its newly designed Sonolith I-Sys lithotripter in the United States.

EDAP TMS SA has received FDA clearance to market its newly designed Sonolith I-Sys lithotripter in the United States.

The integrated lithotripter utilizes the company's patented electroconductive technology. EDAP said the device's superior x-ray and ultrasound imaging systems and user-friendly features have contributed to positive treatment outcomes in Europe, where the product was launched in late 2007.

In related news, Mission Pharmacal has announced that acetohydroxamic acid (Lithostat), a urease inhibitor available for urea-splitting urinary infections in association with struvite stones, is now available at U.S. pharmacies nationwide.

Mission said it has successfully contracted with a new supplier of acetohydroxamic acid to re-introduce Lithostat on the market.

In single clinical trials, the product allowed successful antibiotic treatment of urea-splitting infections after surgical removal of struvite stones in patients not cured by 3 months of antibacterial treatment alone. It also reduced the rate of stone growth in patients who were not candidates for surgical removal of stones, according to the company.

Related Videos
Edward M. Schaeffer, MD, PhD, answers a question during a Zoom video interview
Woman talking with doctor | Image Credit: © rocketclips - stock.adobe.com
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
Gamal M. Ghoniem, MD, FACS, ABU/FPMRS, gives an answer during a video interview
Edward M. Schaeffer, MD, PhD, answers a question during a Zoom video interview
Zhina Sadeghi, MD, answers a question during a video interview
A panel of 4 experts on prostate cancer
Related Content
© 2024 MJH Life Sciences

All rights reserved.